
Current Price | $9.10 | Mkt Cap | $735.6M |
---|---|---|---|
Open | $9.22 | P/E Ratio | -13.42 |
Prev. Close | $9.10 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $9.05 - $9.34 | Volume | 653,851 |
52-Wk Range | $7.36 - $15.24 | Avg. Daily Vol. | 996,384 |
Current Price | $9.10 | Mkt Cap | $735.6M |
---|---|---|---|
Open | $9.22 | P/E Ratio | -13.42 |
Prev. Close | $9.10 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $9.05 - $9.34 | Volume | 653,851 |
52-Wk Range | $7.36 - $15.24 | Avg. Daily Vol. | 996,384 |
The best Bull and Bear pitches based on recency and number of recommendations.
Speculative Pick (2% max allocation would be wise); Sharing my number one stock pick once again; Where many others have failed and gone home, Anavex continues to march towards the first effective treatment for dementia in history; Stock recently fell… More
Been about 4 years since Anavex raised a heap of money after posting "successful" midstage data. How's that phase 3 Alzheimer's study with 2-73 coming along?
Read the most recent pitches from players about AVXL.
Recs
Speculative Pick (2% max allocation would be wise); Sharing my number one stock pick once again; Where many others have failed and gone home, Anavex continues to march towards the first effective treatment for dementia in history; Stock recently fell after they reported positive Phase I results for another candidate in their pipeline (3-71); Investors are too quick to fold their hands; They forget that she is close to completing Phase III testing for her flagship candidate 2-73; 100% of trial study patients have voluntarily signed up for continued treatment under extended long term study protocols since Phase I; Study goals exceed required FDA data points; They’ve also received positive feedback from preliminary FDA reviews with zero change recommendations offered; I predict full FDA approval before year's end; Stock likely to move long before then regardless of what the general market is doing
Recs
Shrinking deficit and improving technicals.
Recs
Been about 4 years since Anavex raised a heap of money after posting "successful" midstage data. How's that phase 3 Alzheimer's study with 2-73 coming along?
Find the members with the highest scoring picks in AVXL.
DorminABC (99.69) Score: +270.07
The Score Leader is the player with the highest score across all their picks in AVXL.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
Under5 | 58.39 |
|
![]() |
5Y | $2.13 | +327.23% | +55.83% | +271.40 | 0 Comment | |
DorminABC | 99.69 | 3/17/2011 |
![]() |
NS | $15.28 | -40.45% | +229.62% | +270.07 | 0 Comment | |
conliskjr | < 20 |
|
![]() |
3Y | $2.79 | +226.16% | +102.21% | +123.96 | 0 Comment | |
whatisthepoint | 94.24 | 10/12/2015 |
![]() |
5Y | $9.52 | -4.41% | +109.83% | +114.24 | 0 Comment | |
SunnySky123 | 24.49 | 6/15/2020 |
![]() |
1Y | $3.74 | +143.32% | +40.32% | +102.99 | 0 Comment | |
Theige | 29.00 | 10/12/2015 |
![]() |
5Y | $8.30 | +9.64% | +109.42% | +99.78 | 0 Comment | |
ttkam20 | < 20 | 8/10/2020 |
![]() |
5Y | $4.19 | +117.18% | +25.89% | +91.29 | 0 Comment | |
portefeuille | 98.43 | 9/22/2016 |
![]() |
5Y | $3.35 | +171.64% | +94.41% | +77.23 | 0 Comment | |
MMCapitalMgmt | 99.96 | 10/23/2015 |
![]() |
5Y | $7.18 | +26.74% | +103.45% | +76.71 | 0 Comment | |
FSaucy | 97.66 | 10/6/2015 |
![]() |
NS | $6.12 | +48.69% | +113.64% | +64.95 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.